Literature DB >> 8448064

The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.

L F Prescott1, S Freestone, J A McAuslane.   

Abstract

1. The disposition and kinetics of p-aminohippuric acid (PAH) were studied in 27 healthy male volunteers, 10 healthy female volunteers and 10 patients with chronic renal impairment following rapid intravenous injection of 10 mg kg-1. In addition, the renal clearances of PAH and its metabolite N-acetyl-PAH were measured in 10 of the healthy male volunteers following conventional administration of PAH by loading dose and constant infusion, and in another eight during sequential 'step-up' and 'step-down' infusions intended to maintain low, medium and high plasma concentrations below the threshold for onset of saturation of tubular transport. 2. PAH was eliminated rapidly with a mean half-life of less than 30 min in the healthy volunteers and 72 min in the renal patients. The corresponding estimates for acetyl-PAH were 49 and 153 min. In both groups the rate of disappearance of PAH slowed progressively over the period of observation and there was no true log-linear terminal elimination phase. 3. In the healthy volunteers about 50% of the dose was excreted in the urine in 30 min with quantitative recovery in 3 h. In 8 h, 17% of the dose was recovered as acetyl-PAH. In the patients with renal impairment the 8 h recovery was only 83.6% of the dose with 26.9% of the total appearing as acetyl-PAH. 4. The volume of distribution (Vss) of PAH was 16-18 l in the healthy subjects and renal patients. Acetyl-PAH appeared to have a much larger distribution volume (mean 65.5 l in the healthy volunteers). 5. In the healthy volunteers the renal clearance of PAH fell dramatically from 599 +/- 115 ml min-1 1.73m-2 during the first hour after administration to 300 +/- 208 ml min-1 1.73 m-2 during the second hour (P < 0.001). The corresponding renal clearances of acetyl-PAH were 775 +/- 196 and 916 +/- 212 ml min-1 1.73 m-2. In the patients with renal impairment the renal clearance of PAH fell from 194 +/- 83 ml min-1 1.73 m-2 in the first hour to only 61 +/- 19 ml min-1 1.73 m-2 from 4 to 6 h. Over the same period there was no significant fall in the clearances of acetyl-PAH or total PAH (acetyl-PAH + PAH).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448064      PMCID: PMC1381485     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  INCONSTANCY OF RENAL CLEARANCE VALUES WITH CHANGING PLASMA CONCENTRATIONS.

Authors:  R B CONN; A J SABO; D LANDES; J Y HO
Journal:  Nature       Date:  1964-07-11       Impact factor: 49.962

2.  Conjugation of p-aminohippurate by the kidney and effective renal plasma-flow.

Authors:  B P SETCHELL; E BLANCH
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

3.  Influence of serum protein binding on renal clearance of I 131-labeled diodrast.

Authors:  J B BLOCK; B A BURROWS
Journal:  J Lab Clin Med       Date:  1960-09

4.  COMPARISON OF THE CONSTANT INFUSION AND URINE COLLECTION TECHNIQUES FOR THE MEASUREMENT OF RENAL FUNCTION.

Authors:  E Y Berger; S J Farber; D P Earle; R Jackenthal
Journal:  J Clin Invest       Date:  1948-11       Impact factor: 14.808

5.  THE USE OF SODIUM p-AMINOHIPPURATE FOR THE FUNCTIONAL EVALUATION OF THE HUMAN KIDNEY.

Authors:  H Chasis; J Redish; W Goldring; H A Ranges; H W Smith
Journal:  J Clin Invest       Date:  1945-07       Impact factor: 14.808

6.  THE SIGNIFICANCE OF THE DIFFERENCE IN SYSTEMIC ARTERIAL AND VENOUS PLASMA CONCENTRATIONS IN RENAL CLEARANCE METHODS.

Authors:  C Brun; T Hilden; F Raaschou
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

7.  Metabolism of p-aminohippurate and its relevance in man.

Authors:  J Girndt; M Mályusz; K W Rumpf; J Neubaur; F Scheler
Journal:  Nephron       Date:  1974       Impact factor: 2.847

8.  Comparison of glomerular filtration rate and effective renal plasma flow determinations obtained by a single injection technique and by means of a standard clearance technique in children.

Authors:  B Vögeli; H Riedwyl; A Donath; O Oetliker
Journal:  Acta Paediatr Scand       Date:  1971-09

9.  Conjugation of para-aminohippuric acid by human kidney and liver slices.

Authors:  G Frindt; S Vial
Journal:  Acta Physiol Lat Am       Date:  1968

10.  Uptake and acetylation of p-aminohippurate by slices of mouse kidney cortex.

Authors:  H M Carpenter; G H Mudge
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

View more
  7 in total

1.  Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis.

Authors:  A Nomura; Y Morita; S Maruyama; N Hotta; M Nadai; L Wang; T Hasegawa; S Matsuo
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Exogenous L-arginine does not affect angiotensin II-induced renal vasoconstriction in man.

Authors:  M Wolzt; A Ugurluoglu; L Schmetterer; G Dorner; G Zanaschka; C Mensik; H G Eichler
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

3.  Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.

Authors:  A S Gross; A J McLachlan; I Minns; J B Beal; S E Tett
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

Review 4.  Principles and clinical application of assessing alterations in renal elimination pathways.

Authors:  Susan E Tett; Carl M J Kirkpatrick; Annette S Gross; Andrew J McLachlan
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.

Authors:  Andrew A Udy; Paul Jarrett; Janine Stuart; Melissa Lassig-Smith; Therese Starr; Rachel Dunlop; Steven C Wallis; Jason A Roberts; Jeffrey Lipman
Journal:  Crit Care       Date:  2014-11-29       Impact factor: 9.097

6.  Conventional Pig as Animal Model for Human Renal Drug Excretion Processes: Unravelling the Porcine Renal Function by Use of a Cocktail of Exogenous Markers.

Authors:  Laura Dhondt; Siska Croubels; Peter De Paepe; Steven C Wallis; Saurabh Pandey; Jason A Roberts; Jeffrey Lipman; Pieter De Cock; Mathias Devreese
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

7.  Simultaneous Measurement of Glomerular Filtration Rate, Effective Renal Plasma Flow and Tubular Secretion in Different Poultry Species by Single Intravenous Bolus of Iohexol and Para-Aminohippuric Acid.

Authors:  Lenka Stroobant; Siska Croubels; Laura Dhondt; Joske Millecam; Siegrid De Baere; Elke Gasthuys; Joachim Morrens; Gunther Antonissen
Journal:  Animals (Basel)       Date:  2020-06-12       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.